In contrast, attenuated improvements in MPS II patients (language function: β =  − 19.84, p = 0.015) align with documented differences in blood–brain barrier permeability between iduronate-2-sulfatase and α-L-iduronidase [2]. Here, IDS is linked to mucopolysaccharidosis type 2.